The North America Biobanking market was valued at USD 1.17 Billion in 2025 and is expected to grow at a CAGR of 6.31%, reaching USD 2.16 Billion by 2035. The market benefits from advanced healthcare infrastructure, increased funding for precision medicine, and strong government support for genomic research. Growing demand for personalized therapies and the expansion of biobanking networks across academic and commercial sectors are expected to enhance market value through the forecast period.
• By specimen type, the human tissues segment held nearly 30% of the market share during the historical period.
• The services segment accounted for the largest revenue share during the historical period.
• Based on application, the clinical diagnostics segment is anticipated to witness significant growth over the forecast period.
Base Year
Historical Period
Forecast Period
In October 2024, Colossal launched The Colossal Foundation with $50 million to support its Biovault biobanking initiative. This is expected to accelerate market growth by driving innovation in genetic preservation and conservation.
Rising prevalence of chronic diseases, growing genomic research, and increasing demand for personalized medicine are key factors propelling the North America biobanking market, significantly boosting its overall growth trajectory.
Major market players are advancing biobanking technologies and expanding strategic collaborations, thereby enhancing infrastructure and innovation, which plays a crucial role in accelerating market expansion across the region.
Compound Annual Growth Rate
6.31%
Value in USD Billion
2026-2035
*this image is indicative*
Biobanking plays a critical role in supporting biomedical research, personalized medicine, and clinical trials across the region. North America continues to dominate the global biobanking market due to advanced healthcare infrastructure, strong research funding, and rising adoption of precision medicine. The region is also experiencing growing collaboration between academic institutions and pharmaceutical companies. The market is poised to grow at a CAGR of 6.31% during the forecast period of 2026–2035, driven by technological advancements and increased demand for genetic and chronic disease research.
Innovative Automation and Sustainability to Drive Growth in the Market
The launch of advanced, automated sample management systems is significantly accelerating the market. For instance, in February 2024, Azenta, Inc. introduced the BioArc™ Ultra, a high-density, eco-friendly ultracold storage solution designed to transform large-scale biorepositories. This automated -80°C system reduces electricity usage by up to 70% and eliminates ozone-depleting refrigerants, aligning with global sustainability goals. Its compact footprint, cost-efficiency, and zero global warming potential make it highly attractive for biobanks seeking scalable, energy-efficient solutions. Such technological advancements are expected to strongly support market expansion and modernize biobanking infrastructure across the region.
Some of the notable trends in the market include data-driven risk modeling and a growing emphasis on standardization and operational excellence.
Data-Driven Risk Modeling is Expected to Boost the Market Value
The growing integration of biobank-linked cohort data in the development of advanced disease risk prediction models is a key trend shaping the biobanking market in North America. For instance, in November 2024, approval of a research project at Sunnybrook Research Institute, which utilized Ontario Health Study (OHS) biosamples to create and validate new models for long-term cardiovascular disease prevention. Such initiatives highlight the increasing reliance on biobank resources for precision medicine and preventive healthcare. This trend is expected to drive the market's expansion by enhancing the clinical relevance of biobanked biospecimens.
Growing Emphasis on Standardization and Operational Excellence is Reshaping the North America Biobanking Market
The rising emphasis on standardization and operational excellence is reshaping the market. A key trend is the integration of robust repository management practices aimed at enhancing quality, compliance, and research value. In 2023, the International Society for Biological and Environmental Repositories (ISBER) released the fifth edition of its Best Practices: Recommendations for Repositories. This updated guidance supports repositories with structured protocols aligned to global expectations. As biobanks adopt these refined practices, market efficiency and credibility are expected to rise, ultimately driving long-term market growth.
Human Tissues Expected to Lead the Market by Specimen Type
The market, when segmented by specimen type, includes blood products, human tissues, cell lines, nucleic acids, biological fluids, human waste products, and others. Among these, the human tissues segment is projected to lead the market. During the historical period, it accounted for approximately 36% of the total share. The increasing focus on personalized medicine, drug discovery, and regenerative therapies continues to drive the demand for preserved human tissues across research and clinical applications.
The regions included in the report are the United States and Canada. Among these, the United States is expected to lead due to its advanced research infrastructure and strong clinical trial networks. For instance, in May 2024, the NSABP Foundation and NRG Oncology relocated their Biospecimen Bank to the Nova Place campus in Pittsburgh. This facility now houses over 1.3 million annotated tumor tissue specimens, reinforcing the U.S. position as a key contributor to oncology research and biobanking innovation across the region.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Thermo Fisher Scientific is a global leader in scientific services and solutions, offering a comprehensive portfolio tailored to biobanking applications. The company provides advanced products for sample collection, preparation, analysis, storage, and transport, alongside robust data and workflow management solutions. Notable offerings include TSX Series Ultra-Low Temperature Freezers, RNAlater®-ICE, and Nunc™ Cryogenic Tubes. Its integrated biobanking solutions ensure sample integrity, enhance data sharing, and support life science discoveries.
QIAGEN offers a robust portfolio of products supporting biobanking, including nucleic acid extraction kits like QIAwave and automated systems such as QIAcuityDx for digital PCR. These technologies streamline sample preparation and genetic analysis, critical for preserving biospecimens. The company’s innovations aid researchers in applications spanning oncology, infectious disease, human identification, and microbiome research.
Illumina Inc., a global leader in DNA sequencing technologies, has initiated a landmark pilot proteomics program in partnership with UK Biobank and major biopharma companies. The study will analyze 50,000 samples using the Illumina Protein Prep™ assay, powered by SOMAmer® technology. This next-generation sequencing-based solution enhances proteomic insights, supports drug discovery, and strengthens the company's role in advancing biomarker research and multiomics innovations.
Avantor, Inc., a prominent provider of life science tools, actively supports biobanking with its WHEATON® product line. The company offers a diverse range of solutions tailored for biological sample preservation, including cryogenic vials, ampules, storage boxes, and barcode readers. These tools facilitate efficient sample storage, identification, and traceability, enhancing laboratory productivity and advancing research and development in healthcare and biosciences.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are Merck KGaA, STEMCELL Technologies, and Coriell Institute for Medical Research.
North America Biobanking Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Specimen Type
Market Breakup by Application
Market Breakup by Ownership
Market Breakup by End Use
Market Breakup by Country
Upto 15% Off
USD
$2699 $2429
$4299 $3869
$5799 $4949
$6999 $5949
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Specimen Type |
|
| Breakup by Application |
|
| Breakup by Ownership |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share